Bone Changes During Growth in Patients with Osteogenesis Imperfecta

被引:0
|
作者
Burgueno-Torres, Laura [1 ]
Garcia-Boedo, Lara [1 ]
de Nova-Garcia, Manuel Joaquin [1 ]
机构
[1] Univ Complutense Madrid, Fac Dent, Dent Clin Specialties Dept, Madrid 28040, Spain
关键词
osteogenesis imperfecta; biphosphonates; orthopantomography; panoramic index; pediatric patient; PANORAMIC MANDIBULAR INDEXES; RADIOMORPHOMETRIC INDEXES; FRACTAL DIMENSION; CHILDREN; PAMIDRONATE; THERAPY; DENSITY; DIAGNOSIS; GENDER; CORTEX;
D O I
10.3390/jcm14051764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Objectives: Osteogenesis Imperfecta (OI) is a congenital disorder, in which the production of collagen, mainly type I, is altered, leading to a decrease in bone mineral density, increasing the risk of fracture with minimal trauma. Several studies have analyzed bone mineral density in osteoporotic patients based on linear measurements such as radiomorphometric indices measured with panoramic radiographs, although few studies have investigated bone trabeculation in children diagnosed with OI. Therefore, the aim of the present investigation was to analyze the dental panoramic indices in panoramic radiographs in the cortical and trabeculated bone of children with OI. Methods: Thus, 66 pediatric patients diagnosed with OI under antiresorptive treatment were compared with a sample of controls matched for sex and age. Using Image J software (version: 1.54d), three radiomorphometric indices were analyzed in orthopantomographies of the study and control groups, evaluating the influence of disease severity as well as the type of antiresorptive treatment administered. Results: Patients with OI had a higher presence of type C2 and C3 MCI (mandibular cortical index) than their matched controls (p < 0.05), although no differences were found for the visual estimation of cortical width (SVE) and mandibular cortical width (MCW). Treatment with zoledronic acid was associated with a higher number of cases of type C1 MCI, in terms of sample description, while patients treated with a combination of pamidronate and zoledronic acid had a higher rate of type C1 and C2 MCI, with no statistical differences. Conclusions: In the overall sample, most patients showed a thin SVE index (59.1%), a C2 or C1 type MCI (46.2% and 42.4%) and an MCW of 2.9 mm. Differences in bone mineral density were also observed throughout growth and the different antiresorptive treatments. Zoledronic acid has been associated with a higher percentage of C1 and C3 ICM, and pamidronate alone or in combination is associated with a C1 and C2 MCI index.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] OSTEOGENESIS IMPERFECTA - COMPARISON OF MOLECULAR DEFECTS WITH BONE HISTOLOGICAL-CHANGES
    SZTROLOVICS, R
    GLORIEUX, FH
    TRAVERS, R
    VANDERREST, M
    ROUGHLEY, PJ
    BONE, 1994, 15 (03) : 321 - 328
  • [22] Prevalence and natural course of craniocervical junction anomalies during growth in patients with osteogenesis imperfecta
    Arponen, Heidi
    Makitie, Outi
    Haukka, Jari
    Ranta, Helena
    Ekholm, Marja
    Mayranpaa, Mervi K.
    Kaitila, Ilkka
    Waltimo-Siren, Janna
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (05) : 1142 - 1149
  • [23] Temporal bone imaging in osteogenesis imperfecta patients with hearing loss
    Swinnen, Freya K. R.
    Casselman, Jan W.
    De Leenheer, Els M. R.
    Cremers, Cor W. R. J.
    Dhooge, Ingeborg J. M.
    LARYNGOSCOPE, 2013, 123 (08): : 1988 - 1995
  • [24] Mechanisms of Crack Growth Toughness in Young Osteogenesis Imperfecta Mouse Bone
    Docaj, Anxhela
    Carriero, Alessandra
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 65 - 66
  • [25] Bone Material Properties in Osteogenesis Imperfecta
    Bishop, Nick
    JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (04) : 699 - 708
  • [26] Osteogenesis Imperfecta and Bone Marrow Transplant
    Madonia, Lara
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2012, 29 (01) : 37 - 44
  • [27] BONE SIMILAR OTOSCLEROSIS IN OSTEOGENESIS IMPERFECTA
    MULLER, E
    ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 1975, 210 (02): : 360 - 361
  • [28] Correlation of Bone Mineral Density on Quality of Life in Patients with Osteogenesis Imperfecta during Treatment with Denosumab
    Hoyer-Kuhn, Heike
    Starke, Christina
    Franklin, Jeremy
    Schoenau, Eckhard
    Semler, Oliver
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2017, 15 : 123 - 129
  • [29] Bone mass and mineralization in osteogenesis imperfecta
    Fratzl-Zelman, Nadja
    Misof, Barbara M.
    Klaushofer, Klaus
    Roschger, Paul
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2015, 165 (13-14) : 271 - 277
  • [30] BONE MATRIX PROTEINS IN OSTEOGENESIS IMPERFECTA
    DICKSON, I
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1976, 84 (03): : R42 - R42